Eszopiclone (Lunesta) and Ketamine Therapy | Tovani Health
Lunesta (Eszopiclone) — Non-benzodiazepine sedative hypnotic (Z-drug)
Verdict at Tovani Health
Compatible; we time sessions to avoid the residual sedation window.
Eszopiclone and ketamine are compatible. The interaction is additive CNS depression and possible next-morning residual impairment. We schedule sessions to avoid the post-dose sedation window.
If you take Lunesta regularly and are considering at-home ketamine therapy, the combination is safe with monitoring or dose adjustment. This page covers the brief pharmacologic context and what we do at intake.
How Lunesta interacts with ketamine
Eszopiclone is a GABA-A modulator with a half-life of about 6 hours. Next-morning impairment is more common at the 3 mg dose. Combined with ketamine, additive sedation in the session window is the main issue.
What we do at intake
Tell us the dose (1 mg, 2 mg, or 3 mg) and bedtime timing. Morning sessions work well if you take it the night before.
Bottom line
Eszopiclone and ketamine are compatible. The interaction is additive CNS depression and possible next-morning residual impairment. We schedule sessions to avoid the post-dose sedation window.
Frequently Asked Questions
Does Lunesta blunt the ketamine response like benzodiazepines do?
The signal is smaller. Z-drugs share the GABA mechanism but the clinical blunting evidence is weaker than for benzodiazepines.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Lunesta (Eszopiclone) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Sources
The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.
- The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication. Andrashko V, Novak T, Brunovsky M, et al.. Frontiers in Psychiatry. 2020. PMID: 33005153
Patients on concomitant benzodiazepines showed a measurably blunted antidepressant response to ketamine.
- Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review. Veraart JKE, Smith-Apeldoorn SY, Bakker IM, et al.. International Journal of Neuropsychopharmacology. 2021. PMID: 34170315
Systematic review of pharmacodynamic interactions between ketamine and psychiatric medications used in depression treatment.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 15, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.